Lecanemab

ATC N06DX04 · 11 markets · 17 records

Lecanemab 11 markets · 17 records Forms

AU 3 records · 2 strengths

100 mg/mLinjectionLEQEMBI lecanemab 200 mg/2 mL concentrated injection vial also in SG unknown

Records without a stated strength · 1 LEQEMBI

US 2 records · 1 strengths

100 mginjectionLEQEMBI

GB 2 records · 2 strengths

500 mg/5 mLinjectionLeqembi 200mg/2ml concentrate for solution for infusion vials
200 mg/2 mLinjectionLeqembi 200mg/2ml concentrate for solution for infusion vials

CN 2 records · 2 strengths

500 mginjection乐意保仑卡奈单抗
200 mginjection乐意保仑卡奈单抗

HK 2 records · 1 strengths

Records without a stated strength · 1 LEQEMBI concentrate for solution for infusion

CA 1 records · 1 strengths

100 mgliquidLEQEMBI

SG 1 records · 1 strengths

100 mg/mLinjectionLEQEMBI CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/ML also in AU

ES 1 records · 1 strengths

100 mg/1 mLinjectionLEQEMBI

MX 1 records · 1 strengths

Records without a stated strength · 1 LEQEMBI

TW 1 records · 1 strengths

Records without a stated strength · 1 LEQEMBI concentrate for solution for infusion、樂意保濃縮靜脈輸注液

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 LEQEMBI

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.